Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/104762
Title: CD26/DPPIV Inhibition alters the expression of immune response-related genes in the thymi of NOD mice
Author: Julian, María Teresa
Alonso, Nuria
Colobran, Roger
Sànchez, Àlex (Sànchez Pla)
Miñarro Alonso, Antonio
Pujol-Autonell, Irma
Carrascal, Jorge
Rodríguez-Fernandez, Silvia
Ampudia, Rosa María
Vives-Pi, Marta
Puig-Domingo, Manel
Keywords: Diabetis
Microxips d'ADN
Expressió gènica
Ratolins (Animals de laboratori)
Diabetes
DNA microarrays
Gene expression
Mice (Laboratory animals)
Issue Date: 5-May-2016
Publisher: Elsevier B.V.
Abstract: The transmembrane glycoprotein CD26 or dipeptidyl peptidase IV (DPPIV) is a multifunctional protein. In immune system, CD26 plays a role in T-cell function and is also involved in thymic maturation and emigration patterns. In preclinical studies, treatment with DPPIV inhibitors reduces insulitis and delays or even reverses the new onset of type 1 diabetes (T1D) in non-obese diabetic (NOD) mice. However, the specific mechanisms involved in these effects remain unknown. The aim of the present study was to investigate how DPPIV inhibition modifies the expression of genes in the thymus of NOD mice by microarray analysis. Changes in the gene expression of β-cell autoantigens and Aire in thymic epithelial cells (TECs) were also evaluated by using qRT-PCR. A DPPIV inhibitor, MK626, was orally administered in the diet for 4 and 6 weeks starting at 6-8 weeks of age. Thymic glands from treated and control mice were obtained for each study checkpoint. Thymus transcriptome analysis revealed that 58 genes were significantly over-expressed in MK626-treated mice after 6 weeks of treatment. Changes in gene expression in the thymus were confined mainly to the immune system, including innate immunity, chemotaxis, antigen presentation and immunoregulation. Most of the genes are implicated in central tolerance mechanisms through several pathways. No differences were observed in the expression of Aire and β-cell autoantigens in TECs. In the current study, we demonstrate that treatment with the DPPIV inhibitor MK626 in NOD mice alters the expression of the immune response-related genes in the thymus, especially those related to immunological central tolerance, and may contribute to the prevention of T1D.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.mce.2016.02.014
It is part of: Molecular and Cellular Endocrinology, 2016, vol. 426, p. 101-112
Related resource: https://doi.org/10.1016/j.mce.2016.02.014
URI: http://hdl.handle.net/2445/104762
ISSN: 0303-7207
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
657427.pdf2.36 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons